SOURCE: Xtalks

Xtalks Webinars

September 08, 2015 15:00 ET

Top Life Science News Stories You Might Have Missed From Xtalks

TORONTO, ON--(Marketwired - September 08, 2015) - Xtalks provides daily news in the life science industry.

Stay up-to-date with the latest in the life science industry by subscribing today. --

Pfizer Finalizes Acquisition of Hospira --
(Sep 8) Pfizer announced it has completed its $17 billion acquisition of US-based pharmaceutical and medical device company, Hospira.

OpenFDA Provides Easy Access to Medical Device Data --
(Sep 8) The Food and Drug Administration (FDA) has expanded the medical device content available on their OpenFDA database.

Antidote Trials Could Boost Sales of the Anticoagulant, Pradaxa --
(Sep 4) Boehringer hopes that launching a bleeding antidote to counteract the effects of the blood thinner may benefit sales of Pradaxa.

Study Finds Transplant Organ Allocation May Be Flawed --
(Sep 4) A group of studies conducted by researchers at Rutgers University in collaboration with the University of California Los Angeles (UCLA), found that making decisions about who should receive an organ transplant depended on the way a patient's information was presented.

Rapid Technique for Identifying Bacterial Antibiotic Resistance --
(Sep 3) Researchers from Arizona State University have developed a technique to identify antibiotic resistant bacteria, and differentiate them from their antibiotic sensitive counterparts.

Premature Birth and Cognitive Impairment: Post-Partum Prediction Using MRI --
(Sep 3) A new study published in the journal Brain, has identified that once children born prematurely reach school age, they are more likely to have a reduction in working memory and lower mathematical scores.

Google and Sanofi Partner to Improve Diabetes Management --
(Sep 2) The French pharmaceutical giant Sanofi, has agreed to support Google's recently established biotech company in an effort to improve disease management for diabetic patients.

First Evidence Shows How Sleep Apnea Affects Brain --
(Sep 2) Researchers at the University of California, Los Angeles (UCLA), have published the first evidence that the blood-brain barrier -- the selectively-permeable layer that protects the brain -- is damaged as a result of obstructive sleep apnea.

Bristol-Myers Announces Intentions to Acquire Promedior --
(Sep 1) The global biopharmaceutical company Bristol-Myers Squibb has announced their plans to buy out Promedior, in a press release yesterday.

New Combo Treatment for Hypertension Reduces Side Effects --
(Sep 1) A new study has found that by administering half doses of two commonly prescribed diuretics, blood pressure can be significantly reduced without the usual side effects these medications cause when they're taken on their own.

Amgen Receives Marketing Approval for Cholesterol Drug Repatha --
(Aug 31) The FDA has approved marketing of Amgen's PCSK9 cholesterol drug, Repatha (evolocumab).

Retinoids May Be Useful in Treatment of High-Risk Leukemia --
(Aug 31) Researchers at St. Jude Children's Research Hospital in Memphis Tennessee, have identified the effects of a mutation common in children with high-risk leukemia, and the types of drugs which may be effective in increasing survival rates.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit

For information about hosting a webinar visit

Contact Information